Advancing Therapy in Basal Insulin-Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

被引：0
|
作者：
Home, Philip
McCrimmon, Rory J.
Rosenstock, Julio
Bluher, Matthias
Pegelow, Katrin
Melas-Melt, Lydie
Djaballah, Khier
Giorgino, Francesco
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-845-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
845-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization study
    Yang, Wenying
    Du, Juan
    Zhang, Minlu
    Hou, Jing
    Zhang, Xia
    Cui, Nan
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1807 - 1814
  • [32] Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus
    Leif Sparre Hermann
    Drugs & Aging, 2000, 17 : 283 - 294
  • [33] Exenatide therapy in insulin-treated type 2 diabetes and obesity
    Nayak, U. A.
    Govindan, J.
    Baskar, V.
    Kalupahana, D.
    Singh, B. M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (09) : 687 - 694
  • [34] Trajectories of HbA1c after initiation of insulin therapy in type 2 diabetes mellitus patients
    Mast, R.
    Walraven, I.
    Hoekstra, T.
    Jansen, D.
    van der Heijden, A. A. W.
    Elders, P. J. M.
    Heine, R. J.
    Dekker, J. M.
    Hugtenburg, J. G.
    Nijpels, G.
    DIABETOLOGIA, 2014, 57 : S385 - S385
  • [35] Optimising therapy for insulin-treated type 2 diabetes mellitus
    Hermann, LS
    DRUGS & AGING, 2000, 17 (04) : 283 - 294
  • [36] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
    Bowering, Keith
    Bode, Bruce W.
    Harris, Stewart B.
    Piletic, Milivoj
    Babu, Vinay
    Dethlefsen, Claus
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A253 - A253
  • [37] Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial
    Paramasivam, S. S.
    Chinna, K.
    Singh, A. K. K.
    Ratnasingam, J.
    Ibrahim, L.
    Lim, L. L.
    Tan, A. T. B.
    Chan, S. P.
    Tan, P. C.
    Omar, S. Z.
    Bilous, R. W.
    Vethakkan, S. R.
    DIABETIC MEDICINE, 2018, 35 (08) : 1118 - 1129
  • [38] Metformin lowers HbA1c and insulin dose in adolescents with poorly controlled type 1 diabetes
    Hamilton, J
    Zdravkovic, V
    Cummings, E
    Finegood, D
    Daneman, D
    DIABETES, 2002, 51 : A427 - A427
  • [39] IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS
    Vigersky, Robert A.
    Huang, Suiying
    Cordero, Toni L.
    Shin, John
    Lee, Scott W.
    Chhabra, Harmeet
    Kaufman, Francine R.
    Cohen, Ohad
    ENDOCRINE PRACTICE, 2018, 24 (05) : 446 - 452
  • [40] Comparing insulin glargine (GLAR) with insulin detemir (DET) - effects on HbA1c on weight change and insulin dose in patients with type 2 diabetes
    Dailey, G.
    Admane, K.
    Mercier, F.
    Owens, D.
    DIABETOLOGIA, 2009, 52 : S381 - S381
12345